Back to All Events

Two sides of AI/ML in drug development: Building methods and translating to impact

“Two Sides of AI/ML in Drug Development: Building Methods and Translating to Impact”
From Target Discovery to Clinical Biomarker Development

The seminar will explore how AI/ML methodologies are developed and applied across the drug discovery and development continuum, with perspectives from both large-molecule and small-molecule innovation environments.

Speakers (Back-to-Back Presentations):

  • Celine Han, PhD
    Computational Biologist, Amgen

  • Eric Ma, PhD
    Senior Principal Data Scientist, Moderna

Date & Time:
Tuesday, February 3, 2026 | 5:00 PM – 9:00 PM

  • 5:00 PM – 6:00 PM: Registration and Dinner

  • 6:00 PM – 7:45 PM: Seminar (Back-to-back talks)

  • 7:45 PM – 9:00 PM: Networking

Location:
CIC Venture Café (5th Floor)
1 Broadway, Cambridge, MA 02142

Previous
Previous
October 21

AI in Drug Development: Turning Breakthroughs into Impact